We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $43.4M | 0.23% |
70,255
+57,465
| +449% | +$32.8M |
|
127
Leidos
LDOS
$14.5B
| $43.2M | 0.23% |
273,999
-2,742
| -1% | -$405K |
|
128
Sysco
SYY
$40.8B
| $42.9M | 0.23% |
+566,915
| New | +$41.2M |
|
129
Zai Lab
ZLAB
$2.06B
| $42M | 0.22% |
1,201,016
| – | – |
|
130
DexCom
DXCM
$31.5B
| $41.8M | 0.22% |
478,399
+2,669
| +0.6% | +$209K |
|
131
Medtronic
MDT
$109B
| $41.5M | 0.22% |
476,360
+433,091
| +1,001% | +$36.7M |
|
|
TMHC
132
DELISTED
Taylor Morrison
TMHC
| $41.4M | 0.22% |
673,838
+491,350
| +269% | +$28.5M |
|
133
Vertex Pharmaceuticals
VRTX
$121B
| $40.8M | 0.22% |
91,664
-61,496
| -40% | -$28.3M |
|
134
Zevra Therapeutics
ZVRA
$562M
| $40.7M | 0.21% |
4,615,676
+51
| +0% | +$414 |
|
135
Procter & Gamble
PG
$336B
| $40.4M | 0.21% |
253,606
+55,501
| +28% | +$9.06M |
|
136
BrightSpring Health Services
BTSG
$11.7B
| $40M | 0.21% |
+1,694,007
| New | +$35.3M |
|
137
Home Depot
HD
$331B
| $39.4M | 0.21% |
107,511
+23,587
| +28% | +$8.54M |
|
138
Air Products & Chemicals
APD
$65.7B
| $39M | 0.21% |
138,375
+119,579
| +636% | +$32.7M |
|
139
STMicroelectronics
STM
$46.7B
| $38.8M | 0.21% |
1,276,647
-1,714,883
| -57% | -$42.5M |
|
140
Cummins
CMI
$87.5B
| $38.6M | 0.2% |
117,759
+68,219
| +138% | +$21.1M |
|
141
Cincinnati Financial
CINF
$27.3B
| $38.5M | 0.2% |
258,648
-69,152
| -21% | -$9.9M |
|
142
Kulicke & Soffa
KLIC
$4.67B
| $38.1M | 0.2% |
1,102,317
+663,650
| +151% | +$21.6M |
|
|
P
143
Everpure Inc
P
$25.7B
| $38M | 0.2% |
660,785
-219,922
| -25% | -$10.9M |
|
144
Apogee Therapeutics
APGE
$10.1B
| $37.8M | 0.2% |
870,208
-190,845
| -18% | -$7.26M |
|
145
nVent Electric
NVT
$24.9B
| $37M | 0.2% |
504,803
+342,098
| +210% | +$21M |
|
146
Chevron
CVX
$392B
| $36.9M | 0.2% |
258,005
+116,805
| +83% | +$16.5M |
|
147
Corteva
CTVA
$52.6B
| $36.8M | 0.19% |
493,203
+435,284
| +752% | +$29M |
|
148
Oracle
ORCL
$374B
| $36.5M | 0.19% |
166,913
+87,172
| +109% | +$14.1M |
|
149
James Hardie Industries
JHX
$15.3B
| $36.2M | 0.19% |
+1,347,866
| New | +$32.6M |
|
|
DAY
150
DELISTED
Dayforce
DAY
| $35.6M | 0.19% |
642,875
+17
| +0% | +$972 |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.